Hu2C3

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameHu2C3
Drug Alias Nameanti-VEGF antibodies (Peregrine)anti-VEGF antibodies (Techniclone)2C3
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanized
Mechanisms of ActionVascular endothelial growth factor receptor antagonists
TargetsVascular endothelial growth factor receptor
Therapy Area/IndicationsPancreatic NeoplasmsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity of Texas Southwestern Medical Center
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAvid Bioservices Inc
Active IndicationsN/A
Inactive IndicationsPancreatic NeoplasmsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A